Review article · 2026 · Open access

Patient and Caregiver Reported Barriers to Cancer Clinical Trial Participation: A Scoping Review

Sarah Scruton, Chisato Ito, Julia Bohnen, Robin Urquhart, Chiquita Hessels, Summer Konechny, Rosilene Kraft, Randy Thompson, Cheryl Ho, Deirdre Weymann, Yvonne Bombard, Emanuel Krebs and 6 more

Cancer Reports, 9(10), e70700 · Published 1 October 2026 · DOI 10.1002/cnr2.70700

Open PDFView at the publisherCite this paper

In brief

“Patient and Caregiver Reported Barriers to Cancer Clinical Trial Participation: A Scoping Review” is a 2026 review article by Sarah Scruton and 17 co-authors, published in Cancer Reports. OpenAlex counts 0 citations as of 22 November 2026. It is open access under a CC BY licence: the full text is free to read at Cancer Reports.

Citations
0
References
205
Authors
18

Abstract

BACKGROUND: The development of cancer treatments relies on patient participation in clinical trials, yet poor recruitment and retention hinder evidence generation. There exists an urgent need for trial designs that address patient-identified barriers, informational gaps, and concerns. The goal of this evidence synthesis was to identify patient- and caregiver-reported barriers to trial participation and retention. METHODS: We conducted a search in PubMed, Ovid MEDLINE, CINAHL Complete, Scopus, and Web of Science to identify studies describing patient- and caregiver-reported barriers to cancer clinical trial participation. Eligible studies included qualitative or quantitative research published in the English language that reported barriers experienced by individuals with cancer or their caregivers. Four authors screened titles and abstracts, followed by full-text review and data abstraction of included studies. Qualitative results were summarized narratively, and quantitative findings were described using descriptive statistics. Barriers and recommendations for improved clinical trial design were categorized into thematic groups. RESULTS: The search yielded 7918 studies, with 131 meeting inclusion criteria. Barriers to trial participation were grouped into three overarching themes: (1) psychosocial barriers (e.g., fear of adverse events, distrust, and perceived limited personal benefit); (2) logistical barriers (e.g., travel requirements and financial burden); and (3) informational barriers (e.g., challenges understanding consent materials). Recommendations emphasized financial and logistical support for participants, appropriate information provision, and fostering trust between patients and trial staff. CONCLUSION: Addressing informational, psychosocial, and logistical obstacles to participation is essential for timely evidence generation. Without meaningful strategies to engage patients and caregivers in clinical trial designs, evidence generation for novel oncology innovations will continue to lag, hampering patient access and appropriate reimbursement.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Scruton, S., Ito, C., Bohnen, J., Urquhart, R., Hessels, C., Konechny, S., Kraft, R., Thompson, R., Ho, C., Weymann, D., Bombard, Y., Krebs, E., Denburg, A., Hanna, T. P., Lim, H. J., Shareen, S., Regier, D. A., & Pollard, S. (2026). Patient and Caregiver Reported Barriers to Cancer Clinical Trial Participation: A Scoping Review. Cancer Reports, 9(10), e70700. https://doi.org/10.1002/cnr2.70700

MLA 9

Scruton, Sarah, et al. “Patient and Caregiver Reported Barriers to Cancer Clinical Trial Participation: A Scoping Review.” Cancer Reports, vol. 9, no. 10, 2026, p. e70700. https://doi.org/10.1002/cnr2.70700.

Chicago

Scruton, Sarah, Chisato Ito, Julia Bohnen, Robin Urquhart, Chiquita Hessels, Summer Konechny, Rosilene Kraft, et al. 2026. “Patient and Caregiver Reported Barriers to Cancer Clinical Trial Participation: A Scoping Review.” Cancer Reports 9 (10): e70700. https://doi.org/10.1002/cnr2.70700.

Harvard

Scruton, S. et al. (2026) ‘Patient and Caregiver Reported Barriers to Cancer Clinical Trial Participation: A Scoping Review’, Cancer Reports, 9(10), p. e70700. doi:10.1002/cnr2.70700.

IEEE

S. Scruton et al., “Patient and Caregiver Reported Barriers to Cancer Clinical Trial Participation: A Scoping Review,” Cancer Reports, vol. 9, no. 10, p. e70700, 2026, doi: 10.1002/cnr2.70700.

BibTeX

@article{scruton2026patient,
  title     = {{Patient and Caregiver Reported Barriers to Cancer Clinical Trial Participation: A Scoping Review}},
  author    = {Scruton, Sarah and Ito, Chisato and Bohnen, Julia and Urquhart, Robin and Hessels, Chiquita and Konechny, Summer and Kraft, Rosilene and Thompson, Randy and Ho, Cheryl and Weymann, Deirdre and Bombard, Yvonne and Krebs, Emanuel and Denburg, Avram and Hanna, Timothy Paul and Lim, Howard John and Shareen, Saadia and Regier, Dean A. and Pollard, Samantha},
  journal   = {Cancer Reports},
  year      = {2026},
  volume    = {9},
  number    = {10},
  pages     = {e70700},
  doi       = {10.1002/cnr2.70700},
  url       = {https://doi.org/10.1002/cnr2.70700}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research

  • cancer clinical trials
  • barriers to clinical trial participation
  • trial retention
  • patient-reported barriers
  • psychosocial barriers
  • logistics barriers
  • information barriers
  • informed consent

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Scruton, S., Ito, C., Bohnen, J., Urquhart, R., Hessels, C., Konechny, S., Kraft, R., Thompson, R., Ho, C., Weymann, D., Bombard, Y., Krebs, E., Denburg, A., Hanna, T. P., Lim, H. J., Shareen, S., Regier, D. A., & Pollard, S. (2026). Patient and Caregiver Reported Barriers to Cancer Clinical Trial Participation: A Scoping Review. Cancer Reports, 9(10), e70700. https://doi.org/10.1002/cnr2.70700

How many times has this paper been cited?

0 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Cancer Reports: sign in and open the PDF from this page.

Who wrote this paper?

Sarah Scruton, Chisato Ito, Julia Bohnen, Robin Urquhart, Chiquita Hessels, Summer Konechny, Rosilene Kraft, Randy Thompson, Cheryl Ho, Deirdre Weymann, Yvonne Bombard, Emanuel Krebs and 6 more.

What is the DOI of this paper?

10.1002/cnr2.70700, permanently at https://doi.org/10.1002/cnr2.70700. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.